Ablashi D V, Levine P H, De Vinci C, Whitman J E, Pizza G, Viza D
Advanced Biotechnologies Inc., Columbia, MD 21046, USA.
Biotherapy. 1996;9(1-3):81-6. doi: 10.1007/BF02628662.
Specific Human Herpes virus-6 (HHV-6) transfer factor (TF) preparation, administered to two chronic fatigue syndrome patients, inhibited the HHV-6 infection. Prior to treatment, both patients exhibited an activated HHV-6 infection. TF treatment significantly improved the clinical manifestations of CFS in one patient who resumed normal duties within weeks, whereas no clinical improvement was observed in the second patient. It is concluded that HHV-6 specific TF may be of significant value in controlling HHV-6 infection and related illnesses.
给两名慢性疲劳综合征患者施用特异性人疱疹病毒6型（HHV-6）转移因子（TF）制剂，可抑制HHV-6感染。治疗前，两名患者均表现出HHV-6感染激活。TF治疗使一名患者的慢性疲劳综合征临床表现显著改善，该患者在数周内恢复了正常工作，而第二名患者未观察到临床改善。结论是，HHV-6特异性TF在控制HHV-6感染及相关疾病方面可能具有重要价值。
